PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 28, 2026Frontiers in Aging3 citationsOpen Access

Use of sensing technologies to assess sleep quality and physical activity levels in nursing home residents with dementia taking nightly psychotropic drugs for sleep disturbance: a cross-sectional study

LBLydia D. BoyleBMBrice MartyKHKristoffer Haugarvoll

Key Points

  • The study aims to explore how sensing technologies can reveal differences in sleep quality and physical activity among nursing home residents with dementia on psychotropic medications.
  • Conducted a cross-sectional study with 47 nursing home residents in Bergen, Norway.
  • Stratified participants based on prescribed nightly psychotropic drug usage.
  • Utilized Garmin tracking devices, a sleep monitor, and traditional questionnaires for data collection.
  • Analyzed sleep metrics including Euclidean Norm Minus One, Sleep Regulatory Index, and Sleep Efficiency.
  • Participants using psychotropic medications experienced longer wake times and poorer sleep regularity.
  • Significant reductions in physical activity were noted in participants on long half-life medications compared to those not on any psychotropic drugs.
  • Digital biomarkers provided detailed distinctions in sleep behaviors and activity levels across different medication groups.

Abstract

Background Sleep disturbances are common in people with dementia and nightly prescribed psychotropic drugs, such as sedatives or antidepressants, can increase risks such as injury, inactivity, and behavioral symptoms. Treatment decisions currently rely on periodic, proxy-rated questionnaires that may miss important daily fluctuations in sleep and activity. We explore whether sensing technologies provide insights into distinct differences in sleep characteristics and activity levels in nursing home residents with dementia who are prescribed nightly psychotropic drugs for sleep disturbances. Methods Forty-seven participants were recruited from four nursing homes in Bergen, Norway, and stratified according to prescribed nightly psychotropic drug use for sleep disturbance: 1) none, 2) medications with short half-lives, 3) medications with long half-lives. Garmin Vivoactive5 and Venu3, Vital Things Somnofy sleep monitor, and traditional questionnaires (Physical Self Maintenance Scale and Neuropsychiatric Inventory-Nursing Home version) were used for data collection. Digital metrics included Euclidean Norm Minus One (ENMO; day/night/24-h), Sleep Regulatory Index (SRI), Sleep Efficiency (SE), Total Sleep Time (TST), Sleep Fragmentation Index (SFI), and no presence (time out of bed). Results Thirty participants (73–100 years old) were included for analysis. Groups taking psychotropic medications were awake for longer periods (WASO: chi 2 = 8.7, p = 0.01) and had poorer sleep regularity (SRI: chi 2 = 20.6, p = 0.0001). Participants taking psychotropic drugs had less physical activity (day/night/24-h ENMO), with greatest differences between those on medications with a long half-life (day: chi 2 = 9.48, p = 0.009; night: chi 2 = 12.83, p = 0.002; 24-h: chi 2 = 8.23, p = 0.02) and those not on nightly psychotropic medications. Conclusion The digital biomarkers collected using the selected sensing technologies offered nuanced information regarding sleep behaviors and physical activity levels, providing detailed distinction between the groups. Sensing technologies may be a promising companion to the currently used proxy-rated assessment tools for sleep disturbance and physical activity levels for people with dementia residing in nursing homes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Boyle et al. (2026) studied this question.

synapsesocial.com/papers/69a285aa0a974eb0d3c00b50https://doi.org/10.3389/fragi.2026.1768935
Ask AI
Helpful
Bookmark
Share
View Full Paper